Reduced Ovarian Glyoxalase-I Activity by Dietary Glycotoxins and Androgen Excess: A Causative Link to Polycystic Ovarian Syndrome
Open Access
- 31 July 2012
- journal article
- Published by Springer Nature in Molecular Medicine
- Vol. 18 (8) , 1183-1189
Abstract
Glyoxalase detoxification system composed of glyoxalase (GLO)-I and GLO-II is ubiquitously expressed and implicated in the protection against cellular damage because of cytotoxic metabolites such as advanced glycation end products (AGEs). Recently, ovarian tissue has emerged as a new target of excessive AGE deposition and has been associated with either a high AGE diet in experimental animals or hyperandrogenic disorders such as polycystic ovarian syndrome (PCOS) in humans. This study was designed to investigate the impact of dietary AGEs and androgens in rat ovarian GLO-I activity of normal nonandrogenized (NAN, group A, n = 18) and androgenized prepubertal (AN) rats (group B, n = 29). Both groups were further randomly assigned, either to a high-AGE (HA) or low-AGE (LA) diet for 3 months. The activity of ovarian GLO-I was significantly reduced in normal NAN animals fed an HA diet compared with an LA diet (p = 0.006). Furthermore, GLO-I activity was markedly reduced in AN animals compared with NAN (p ≤ 0.001) when fed with the corresponding diet type. In addition, ovarian GLO-I activity was positively correlated with the body weight gain (r(s) = 0.533, p < 0.001), estradiol (r(s) = 0.326, p = 0.033) and progesterone levels (r(s) = 0.500, p < 0.001). A negative correlation was observed between GLO-I activity and AGE expression in the ovarian granulosa cell layer of all groups with marginal statistical significance (r(s) = -0.263, p = 0.07). The present data demonstrate that ovarian GLO-I activity may be regulated by dietary composition and androgen levels. Modification of ovarian GLO-I activity, observed for the first time in this androgenized prepubertal rat model, may present a contributing factor to the reproductive dysfunction characterizing PCOS.Keywords
This publication has 33 references indexed in Scilit:
- Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucoseExperimental Cell Research, 2012
- Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic RatsJournal of Biological Chemistry, 2011
- Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- High Fat and Highly Thermolyzed Fat Diets Promote Insulin Resistance and Increase DNA Damage in RatsExperimental Biology and Medicine, 2009
- Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndromeFertility and Sterility, 2009
- Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney modelKidney International, 2007
- A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cellsBreast Cancer Research and Treatment, 2005
- Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndromeClinical Endocrinology, 2004
- Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycationBiochemical Society Transactions, 2003
- Prevention of diabetic nephropathy in mice by a diet low in glycoxidation productsDiabetes/Metabolism Research and Reviews, 2002